Vuélvete ilimitado con Magzter GOLD
Obtenga acceso ilimitado a más de 9000 revistas, periódicos e historias Premium por solo
Intentar ORO - Gratis
Intas Pharma bags another overseas co
Mint Mumbai
|January 08, 2025
Gujarat-based drug-maker Intas Pharmaceuticals Ltd, which counts private equity firm ChrysCapital, Singapore state investment firm Temasek and Abu Dhabi Investment Authority (ADIA) as its investors, has signed a deal to acquire a biologic medication brand from US-based Coherus Biosciences.
Intas Pharma has agreed to buy Udenyca brand through its US specialty division, Accord BioPharma, for up to $558.4 million (nearly ₹4,800 crore), according to a press release.
Udenyca is the brand name for medication pegfilgrastim-cbqv, a bone marrow stimulant used to treat low white blood-cell counts in patients who take cancer medications.
Esta historia es de la edición January 08, 2025 de Mint Mumbai.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Mint Mumbai
Mint Mumbai
The world sees hope for a two-state solution. Israelis and Palestinians see none.
Rising global chagrin with Israel is leading to a push to revive the two-state solution. This may be its last chance
5 mins
September 22, 2025
Mint Mumbai
PRIVATE CAPITAL REVIVAL STAYS ELUSIVE. ARE INVESTORS TO BLAME?
Even before Aamir Khan immortalised the character of Rancho in the movie Three Idiots, Bertie had met a real-life Rancho. Duke was Bertie’s senior and dorm-mate in college, and it was well-known on campus that he would join his family business after graduating.
2 mins
September 22, 2025
Mint Mumbai
The myth of market buoyancy has multiple holes in it
A recent research report from a prominent Mumbai brokerage house has shocked Indian capital markets by lifting the veil over the Indian stock market's nonperformance.
3 mins
September 22, 2025
Mint Mumbai
Govt scans prices for profiteering as tax cuts kick in
As the biggest reform in India's goods and services taxes (GST) rolls out today, the Centre will be monitoring whether companies actually pass on the tax cuts or keep the gains to themselves.
3 mins
September 22, 2025
Mint Mumbai
Vengeance is far harder to carry out than it may seem
n June last year, aman named Renukas-wamy, who worked ina medical shop, was found dead miles away from home in a drain in Bangalore.
4 mins
September 22, 2025
Mint Mumbai
H-1B fee hike spells gloom for Indian IT
Bigger firms may handle costs better, other sectors affected too
3 mins
September 22, 2025
Mint Mumbai
PM asks small businesses, states to back swadeshi movement
Prime Minister Narendra Modi on Sunday appealed to states and micro, small, and medium enterprises (MSMEs) to play a key role in boosting the domestic manufacturing sector with globally acclaimed quality products that will fuel India’s pursuit of prosperity on the back of a swadeshi movement.
1 mins
September 22, 2025
Mint Mumbai
ChrysCapital to whip up a $200 million dessert storm
India-focused private equity firm ChrysCapital is sweetening its portfolio with a $200-million push into the desserts space, following last month's acquisition of patisserie chain Theobroma, two people familiar with the matter said on condition of anonymity.
2 mins
September 22, 2025
Mint Mumbai
'Skill education to join school syllabus'
The government is considering to add skill based learning be incorporated in the curriculum of Class 11 and 12 as per the recommendations of the National Education Policy 2020 (NEP 2020), Union minister Dharmendra Pradhan said on Sunday.
1 min
September 22, 2025
Mint Mumbai
Govt may not fine green project exits
Until now, such surrender of projects wasn't allowed. In case developers sought to abandon projects, the government forfeited their bank guarantees
3 mins
September 22, 2025
Listen
Translate
Change font size